Is my molecule suitable for an Orally Disintegrating Tablet

March 13, 2024

Remove from favorites

Add to favorites

Orally Disintegrating Tablets (ODTs) are a favored option for patients, providing added advantages in terms of delivering and absorbing the active pharmaceutical ingredient (API) before reaching the stomach. Incorporating ODT formulation can be beneficial not only for new drug introductions but also for managing the life cycle of existing products, utilizing regulatory pathways such as 505(b)(2) or equivalents. The suitability of an API for ODT formulation relies on various factors, including the desired delivery site and its physicochemical characteristics. Moreover, ongoing advancements aim to further enhance the capabilities of this technology.